Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $135-Report released on 8th February 2024
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Zimmer Biomet Holdings (ZBH) and raises the price target from $133 to $135 as of 8th February 2024.
February 09, 2024 | 10:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Hold rating on Zimmer Biomet Holdings and increases the price target from $133 to $135.
The increase in the price target by Truist Securities suggests a positive outlook on the stock's value, potentially leading to increased investor confidence and a short-term positive impact on the stock price. However, the Hold rating indicates that the analyst does not see significant upside or downside in the near term, tempering the potential price movement.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100